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Gender Differences in Takotsubo Cardiomyopathy as a Secondary Diagnosis: Higher 
Hospital Charges, More Procedures, and Longer Length of Stays
Daniel E. Westerdahl, MD, Hsin-Fang Li, PhD, Amir Yazdani, Kateri J. Spinelli, PhD, Ty J. Gluckman, MD
Background
• The incidence of Takotsubo Cardiomyopathy (TC) has risen steadily over the past decade, with 
current estimates of 15-30 cases per 100,000 per year1
• It has been previously reported that men diagnosed with TC have worse outcomes than 
women2,3
• The relationship between total hospital charges, number of procedures performed, and length of 
stay (LOS) between genders has not been previously reported with TC as a secondary 
diagnosis. 
Results 1
• During 2009-2016, 1,786 males and 11,204 females with secondary TC were identified, 
corresponding to a national estimate of 8,814 males and 55,163 females. 
• Males had higher rates of alcohol and drug abuse, females had higher rates of depression and 
hypothyroidism (Table 1)
• Number of procedures performed, in-hospital death, hospital charges, and LOS was higher for 
men; average age was higher for women (Table 2)
• Total charges increased over time for both males and females, while number of procedures, 
LOS, and severity remained largely flat (Figure 1)
• Applying propensity matching for age and number of procedures (Model 4), the difference in 
median total charges between men and women decreased to $1,658, difference in LOS 
decreased to 0.3 days, and difference in mortality decreased to 1.3% (Figure 2 and Table 2)
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Methods
• Retrospective cohort study using National Inpatient Sample (NIS) data from 2009-2016
• Inclusion criteria: encounters with age ≥ 18 who received a diagnostic coronary angiogram 
(CCS 47), with a secondary diagnosis of TC (ICD 9 code 429.83; ICD 10 code I51.81)
• Exclusion criteria: diagnostic angiography that was followed by percutaneous or surgical 
coronary revascularization (CCS 44 or 45)
• Demographics, comorbidities and outcomes including hospital mortality, total charges, and LOS 
were assessed and stratified by gender
• Continuous variables were described using means. Total charges and LOS were described 
using medians and interquartile ranges. 
• TC encounters were propensity matched by age, number of chronic conditions, number of 
procedures performed, and severity of illness within each year and combined for the analysis.
• The performance of the matching approach was compared with inverse probability weighting 
approach.
• A discharge weight was included in all analyses to account for the complex sample design of 
the NIS
Conclusions
• Compared to women, men with a secondary diagnosis of TC are more likely to have a greater 
number of procedures, leading to a longer LOS and ~$9,000 more in hospital charges
• Propensity matching on age and # of procedures reduced the gender gap
• For the top 10 procedures performed, males experienced a delay in receiving the procedure
• Greater awareness of TC as a potential secondary diagnosis is warranted among men
Results 2
• Model IV has a better overlap between female and male distribution compared to model II 
indicating a better comparison between the 2 groups (Figure 3).
• Performance of one-to-one matching and inverse probability weighting for model IV is 
comparable (Table 3).
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Unmatched 1 to 1 IPW
Variable Male Female Male Female Male Female
LOS, median 4.3 3.6 4.3 4.0 4.4 4.1
Total charges, median 54,655 45,455 54,655 52,997 56,142 54,452
Diff. in charges +9,200 +1,658 +1690
Diff. in LOS +0.7 +0.3 +0.3
Table 3: Propensity Score Methods by Matching and Inverse Probability Weights (IPW)
* Matching variables: age, # procedures (Model 4)
Figure 1 – Gender differences in secondary TC. For both males (A) and females (B), there 
was an increase in total charges over time. LOS, number of procedures, and total charges 
were overall higher for males compared to females. 
Hypothesis
Under recognition of TC in males leads to increased number of procedures, higher hospital 
charges, longer length of stays, and worse outcomes. 
Figure 2 – Propensity-matched models: Difference in median charges (A) and median 
LOS (B) between males and females, unmatched and propensity-matched by four 
separate models. Matching variables for each model provided in Table 3. 
Unmatched
Model 1











Variable Male Female Male Female Male Female Male Female Male Female
N 1448 9404 1448 1429 1448 1432 1448 1429 1448 1432
Age 62.3 67.6 62.3 63.8 62.3 63.4 62.3 63.5 62.3 62.7
# Chronic 
conditions* 8.2 8.1 8.2 8.1 8.2 8.4 8.2 8.0 8.2 8.2
Severity** 2.9 2.6 2.9 2.6 2.9 3.0 2.9 2.7 2.9 2.8
In-hospital 
death, % 5.5 3.3 5.5 2.2 5.5 3.7 5.5 3.7 5.5 4.2
# Procedures 5.2 4.5 5.2 4.5 5.2 5.0 5.2 5.0 5.2 5.2
LOS, median 4.3 3.6 4.3 3.5 4.3 4.6 4.3 3.6 4.3 4.0
Total charges, 
median 54,655 45,455 54,655 43,987 54,655 54,248 54,655 48,187 54,655 52,997
∆ in charges +9,200 +10,668 +407 +6,468 +1,658
∆ in LOS +0.7 +0.8 -0.3 +0.7 +0.3
Table 2: Outcomes before and after propensity matching
* Number of chronic conditions not available within the NIS data set for Q4-2015 and 2016
** Severity of illness subclass within each base APR DRG, scale 0-4 (0=no class specified, 1=minor loss of function, 2=moderate loss of function, 3=major loss 
of function, 4=extreme loss of function)
Data  combined from 2009-2015
Figure 3 – Distribution of propensity scores for Model II and Model IV
Variable Male Female
Unadjusted N 1448 (13%) 9404 (87%)
Weighted N 7124± 197 46,163 ± 562
Age >65, % ± SE 47.4 ± 1.3 61.4 ± 0.5
Age, years 62.3 ± 0.4 67.6 ± 0.1
In-hospital death, % ± SE 5.5 ± 0.6 3.3 ± 0.2
# Procedures 5.25 ± 0.09 4.47 ± 0.03
# Chronic conditions* 8.18 ± 0.08 8.09 ± 0.04
Severity** 2.94 ± 0.03 2.64 ± 0.01
LOS, median (IQR) 4.3 (2.1, 8.7) 3.6 (1.9, 6.9)
Total charges, median (IQR) $54,655 (32535, 110456) $45,455 (28716, 81213)
Comorbidities*, %
Alcohol abuse 13.2% 3.4%
Congestive heart failure 18.8% 15.9%
Chronic pulmonary disease 31.7% 31.0%
Depression 10.7% 17.5%
Diabetes, uncomplicated 18.9% 20.3%
Diabetes with chronic complications 3.7% 3.0%




Renal failure 10.9% 9.4%
Table 1: Demographics and comorbidities
Data presented as n (%) or mean ± SE, unless otherwise indicated
* Number of chronic conditions and comorbidity info not available within the NIS data set for Q4-2015 and 2016
** Severity of illness subclass within each base APR DRG, scale 0-4 (0=no class specified, 1=minor loss of function, 2=moderate loss 
of function, 3=major loss of function, 4=extreme loss of function)
